- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
University of Dundee Wins UK Grant to Boost Discovery of New Antibacterial Drugs
March 27, 2017
The University of Dundee (UK) has been awarded almost £1 million ($1.56 m) to boost efforts to find new new antibiotics to tackle bacterial infections.
The competitive award from Innovate UK, the UK’s innovation agency, will enable the University to create an Antibacterial Drug Discovery Accelerator and further build on the world-leading work carried out in its Drug Discovery Unit.
The grant will be spent on converting existing and appropriately located space into a medicinal chemistry laboratory that, together with existing infrastructure, will create the Antibacterial Drug Discovery Accelerator.
IMF Chief Medical Officer Discusses Global Initiatives to Improve Myeloma Treatment
August 20th 2024In an interview with Pharm Exec Associate Editor Don Tracy, Joseph Mikhael, chief medical officer, IMF, offers a glimpse at multiple initiatives that the IMF is working towards to improve myeloma treatment globally.
